Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alprostadil with Indirect Revascularization in CLI
NCT04312555Phase 4Unknown
- Sponsor
- Assiut University
- Start
- Apr 2020
- Primary completion
- Apr 2021
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
01
Overview
A Phase 4 trial of Alprostadil Liposomes for Injection in critical limb ischemia (CLI), sponsored by Assiut University. Status: unknown.
02
Drugs
Alprostadil Liposomes for Injection
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT04312555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04312555.